Vollenweider FX,Preller KH .2020 .Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders. Nat Rev Neurosc, 21(11) : 611-24.
Nutt D,Erritzoe D,Carhart-Harris R .2020 .Psychedelic psychiatry's brave new world. Cell, 03(1) : 24-8.
Karthik S,Sharma LP,Narayanaswamy JC .2020 .Investigating the role of glutamate in obsessive-compulsive disorder: current perspectives. Neuropsychiatr Dis Treat, 16 : 1003-13.
Paulus MP,Thompson WK,Liu Q,He H,Yang J,Feng X,Zhao F,Lyu J,McClure-Begley TD,Roth BL,Rhee TG,Olfson M,Nierenberg AA,Wilkinson ST,Sartori SB,Singewald N.,García-Gaytán AC,Hernández-Abrego A,Díaz-Muñoz M,Méndez I. .2022 .Glutamatergic system components as potential biomarkers and therapeutic targets in cancer in non-neural organs. Front Endocrinol, 13(8) : 1029210-15.
Baldessarini RJ,Tondo L,Vázquez GH .2019 .Pharmacological treatment of adult bipolar disorder. J Mol Psychiatry, 24(2) : 198-217.
McIntyre RS .2022 .Rapid-acting antidepressants in psychiatry: psychedelics, episodic treatments, innovation, and clarion call for methodologic rigor in drug development. Expert Opin Drug Saf, 21(6) : 715-6.
Staudt MD,Herring EZ,Gao K,Miller JP,Sweet JA .2019 .Evolution in the treatment of psychiatric disorders: from psychosurgery to psychopharmacology to neuromodulation. Front Neurosci, 13 : 108.
Correll CU,Cortese S,Croatto G,Monaco F,Krinitski D,Arrondo G .2021 .Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. Curr Psychiatry, 20(2) : 244-75.
Bousman CA,Bengesser SA,Aitchison KJ,Amare AT,Aschauer H,Baune BT .2021 .Review and consensus on pharmacogenomic testing in psychiatry. Int Pharmacopsychiatry, 54(01) : 5-17.